Moderna said it planned an approximately 20% reduction in expected research and development expenses for 2025 to 2028 from $20 billion to $16 billion.
Moderna reveals plan to slice research and development spending
→
Earlier this year, the Cape Town company attempting to replicate Moderna Inc.’s COVID-19 shot said it had successfully made a candidate vaccine that will soon start laboratory testing.
WHO works to spread COVID vaccine technology to more nations
→